* Plans to develop KP511 as an abuse-deterrent, ER medication for treatment of moderate to severe pain
The post BRIEF-Kempharm says filed IND application with U.S. FDA for KP511 appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Plans to develop KP511 as an abuse-deterrent, ER medication for treatment of moderate to severe pain
The post BRIEF-Kempharm says filed IND application with U.S. FDA for KP511 appeared first on NASDAQ.